More importantly for muscle-focused applications, the proportion of lean mass loss to total weight loss was similar to or better than other obesity treatments, with Retatrutide demonstrating significant improvements in total body fat mass reduction compared to both placebo and dulaglutide (a single-receptor GLP-1 agonist)
Instead of focusing on how treatment affects markers of glycemic control, which has not shown benefit, treatments should be based on anticipated reductions in cardiovascular and kidney disease outcomes
Pharmaceutical expiry dates arent arbitrary theyre backed by stability testing that checks how a drug behaves under heat, light, and humidity
Lifestyle Factors Affecting Endocrine Function Nutritional status, body composition, exercise habits, and sleep quality all exert measurable influences on GH pulsatility and IGF-1 levels
Serious but rare side effects include pancreatitis, gallbladder disease, gastroparesis (stomach paralysis), hypoglycemia, and kidney disease
Always check with a medical professional before making medical decisions